CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
University of California, Los Angeles |
Dr. Richard Joseph Pietras |
Quest – Discovery Stage Research Projects |
Reversal of dysregulated myelopoiesis in breast cancers and cancer stem cells to boost antitumor immunotherapy |
$2,327,680 |
Greenstone Biosciences, Inc. |
Paul D Pang |
Quest – Discovery Stage Research Projects |
Drug Discovery for Duchenne Muscular Dystrophy Using Patient-Derived Human iPSCs |
$675,000 |
University of California, Berkeley |
Mr. Fyodor Urnov |
Quest – Discovery Stage Research Projects |
A Treatment for Artemis-deficient Severe Combined Immunodeficiency using Non-Viral CRISPR-driven Safe Harbor Transgenesis in Hematopoietic Stem Cells |
$1,809,372 |
University of California, Davis |
Aijun Wang PhD |
Quest – Discovery Stage Research Projects |
In Utero Treatment of Duchenne Muscular Dystrophy with Non-viral Gene Editing |
$2,035,544 |
Rubedo Life Sciences Inc. |
Marco Quarta |
Quest – Discovery Stage Research Projects |
Pharmacological regenerative treatment of idiopathic pulmonary fibrosis targeting the senescent niche of lung progenitor cells. |
$1,450,876 |
University of California, Los Angeles |
Dr. Gerald Lipshutz |
Quest – Discovery Stage Research Projects |
Gene Therapy for SLC6A8 Creatine Transporter Disorder |
$2,296,920 |
University of California, Los Angeles |
Frank Pajonk |
Quest – Discovery Stage Research Projects |
Development of novel small molecules against cancer stem cells in solid cancers |
$2,340,000 |
Scripps Health |
Dr. Darryl D. D’Lima |
Quest – Discovery Stage Research Projects |
Pluripotent Stem Cells for Tendon Tissue Engineering |
$2,734,163 |
Cedars-Sinai Medical Center |
Dmitriy Sheyn |
Quest – Discovery Stage Research Projects |
Microgel encapsulated iPSC-derived notochordal cells to treat intervertebral disc degeneration and low back pain |
$2,020,166 |
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Dr. Michelina Iacovino PhD |
Quest – Discovery Stage Research Projects |
A Novel Therapy for Sanfilippo B |
$2,297,884 |
University of California, Berkeley |
5106433559 Kevin E. Healy |
Quest – Discovery Stage Research Projects |
Novel Lipid Nanoparticles for Enhancing eNOS Synthesis for Cardioprotection Post Myocardial Infarction |
$2,060,248 |
BrainXell Therapeutics |
Matthew Goodus |
Quest – Discovery Stage Research Projects |
Autologous stem cell-derived interneuron cell therapy for spinal cord injury (SCI) |
$2,025,000 |
University of California, San Diego |
Professor Alysson R Muotri |
Quest – Discovery Stage Research Projects |
A treatment for Rett syndrome using glial-restricted neural progenitor cells |
$1,402,240 |
Gladstone Institutes, J. David |
Dr. Deepak Srivastava |
Quest – Discovery Stage Research Projects |
Modified RNA-Based Gene Therapy for Cardiac Regeneration Through Cardiomyocyte Proliferation |
$1,565,784 |
The Scintillon Institute |
Brian Lawson |
Quest – Discovery Stage Research Projects |
An hematopoietic stem-cell-based approach to treat HIV employing CAR T cells and anti-HIV broadly neutralizing antibodies. |
$1,143,600 |
University of California, Irvine |
Dr. Michael Demetriou |
Quest – Discovery Stage Research Projects |
CAR T cells targeting abnormal N-glycans for the treatment of refractory/metastatic solid cancers |
$1,414,800 |
University of California, Los Angeles |
Dr. Lili Yang |
Quest – Discovery Stage Research Projects |
Combating Ovarian Cancer Using Stem Cell-Engineered Off-The-Shelf CAR-iNKT Cells |
$1,404,000 |
Minutia, Inc. |
Katy Digovich |
Quest – Discovery Stage Research Projects |
Bioengineering human stem cell-derived beta cell organoids to monitor cell health in real time and improve therapeutic outcomes in patients |
$1,198,550 |
Nanotools Bioscience |
Dr. Alex Savtchenko PhD |
Quest – Discovery Stage Research Projects |
Enabling non-genetic activity-driven maturation of iPSC-derived neurons |
$675,000 |
University of California, Los Angeles |
Dr. Xian-Jie Yang |
Quest – Discovery Stage Research Projects |
Developing gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models |
$1,345,691 |
University of California, San Diego |
Dr. Joseph G. Gleeson |
Quest – Discovery Stage Research Projects |
Novel antisense therapy to treat genetic forms of neurodevelopmental disease. |
$1,180,654 |
Scripps Research Institute |
Stuart A Lipton |
Quest – Discovery Stage Research Projects |
Drug Development of Inhibitors of Inflammation Using Human iPSC-Derived Microglia (hiMG) |
$1,658,123 |
University of California, Los Angeles |
Dr Dinesh S Rao |
Quest – Discovery Stage Research Projects |
Novel methods to eliminate cancer stem cells |
$1,384,347 |
University of California, San Diego |
Dr. Michael Karin |
Quest – Discovery Stage Research Projects |
Targeting pancreatic cancer stem cells with DDR1 antibodies. |
$1,425,600 |
Cedars-Sinai Medical Center |
Dr. Robert Barrett |
Quest – Discovery Stage Research Projects |
A new precision medicine based iPSC-derived model to study personalized intestinal fibrosis treatments in pediatric patients with Crohn’s disease |
$776,340 |
Scripps Research Institute |
Dr Michael J Bollong |
Quest – Discovery Stage Research Projects |
Therapeutics to overcome the differentiation roadblock in Myelodysplastic Syndrome (MDS) |
$1,244,160 |
University of California, Davis |
Dr. Kyle D Fink PhD |
Quest – Discovery Stage Research Projects |
AAV-dCas9 Epigenetic Editing for CDKL5 Deficiency Disorder |
$1,429,378 |
University of California, Los Angeles |
Dr. Caroline Y. Kuo |
Quest – Discovery Stage Research Projects |
Defining the Optimal Gene Therapy Approach of Human Hematopoietic Stem Cells for the Treatment of Dedicator of Cytokinesis 8 (DOCK8) Deficiency |
$1,386,232 |
University of California, Los Angeles |
Dr. Donald B. Kohn PhD |
Quest – Discovery Stage Research Projects |
Hematopoietic Stem Cell Gene Therapy for Alpha Thalassemia |
$1,177,739 |
Stanford University |
Dr. Judith A Shizuru |
Quest – Discovery Stage Research Projects |
Targeted Immunotherapy-Based Blood Stem Cell Transplantation |
$1,341,910 |
Tenaya Therapeutics, Inc. |
Karl N Doerner |
Quest – Discovery Stage Research Projects |
Cardiac Reprogramming Gene Therapy for Post-Myocardial Infarction Heart Failure |
$1,017,000 |
Intact Therapeutics, Inc. |
Jeffrey Linhardt |
Quest – Discovery Stage Research Projects |
Modulation of oral epithelium stem cells by RSpo1 for the prevention and treatment of oral mucositis |
$942,050 |
Cytonus Therapeutics, Inc. |
Dr. Edward Filardo |
Quest – Discovery Stage Research Projects |
Development of a novel stem-cell based carrier for intravenous delivery of oncolytic viruses |
$899,342 |
Salk Institute for Biological Studies |
Ronald Mark Evans |
Quest – Discovery Stage Research Projects |
Extending Immune-Evasive Human Islet-Like Organoids (HILOs) Survival and Function as a Cure for T1D |
$1,523,285 |
Stanford University |
Ansuman Satpathy |
Quest – Discovery Stage Research Projects |
Preclinical development of an exhaustion-resistant CAR-T stem cell for cancer immunotherapy |
$1,420,200 |
Stanford University |
Dr. Bertha Chen |
Quest – Discovery Stage Research Projects |
iPSC-derived smooth muscle cell progenitor conditioned medium for treatment of pelvic organ prolapse |
$1,420,200 |
University of California, San Francisco |
Brian Feeley |
Quest – Discovery Stage Research Projects |
Matrix Assisted Cell Transplantation of Promyogenic Fibroadipogenic Progenitor (FAP) Stem Cells |
$1,179,478 |
University of California, Los Angeles |
Prof. Song Li |
Quest – Discovery Stage Research Projects |
iPSC Extracellular Vesicles for Diabetes Therapy |
$1,354,928 |
Scripps Health |
Dr. Darryl D. D’Lima |
Quest – Discovery Stage Research Projects |
Meniscal Repair and Regeneration |
$1,361,775 |
The Stone Research Foundation for Sports Medicine and Arthritis |
Dr. Kevin Stone |
Quest – Discovery Stage Research Projects |
A Novel Therapy for Articular Cartilage Autologous Cellular Repair by Paste Grafting |
$1,180,309 |
University of California, San Diego |
Gene Wei-Ming Yeo |
Quest – Discovery Stage Research Projects |
RNA-directed therapy for Huntington’s disease |
$1,253,110 |
University of California, Irvine |
Dr. Mathew Mark Blurton-Jones |
Quest – Discovery Stage Research Projects |
Transplantation of genetically corrected iPSC-microglia for the treatment of Sanfilippo Syndrome (MPSIIIA) |
$1,083,379 |
University of California, San Francisco |
Dr. Julie Deane Saba |
Quest – Discovery Stage Research Projects |
Providing a cure for sphingosine phosphate lyase insufficiency syndrome (SPLIS) through adeno-associated viral mediated SGPL1 gene therapy |
$1,463,400 |
Scripps Research Institute |
Luke L Lairson |
Quest – Discovery Stage Research Projects |
Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs |
$1,554,126 |
University of California, San Francisco |
Dr Julia Carnevale |
Quest – Discovery Stage Research Projects |
Generating deeper and more durable BCMA CAR T cell responses in Multiple Myeloma through non-viral knockin/knockout multiplexed genome engineering |
$1,463,368 |
Stanford University |
Dr. Sarah C Heilshorn |
Quest – Discovery Stage Research Projects |
Injectable, autologous iPSC-based therapy for spinal cord injury |
$789,000 |
Navega Therapeutics |
Ana Maria Moreno |
Quest – Discovery Stage Research Projects |
Optimization of a gene therapy for inherited erythromelalgia in iPSC-derived neurons |
$1,157,313 |
Cedars-Sinai Medical Center |
Dr Eduardo Marban |
Quest – Discovery Stage Research Projects |
New noncoding RNA chemical entity for heart failure with preserved ejection fraction. |
$1,397,412 |
Stanford University |
Dr. Stanley Qi |
Quest – Discovery Stage Research Projects |
A novel hybrid CRISPR tool for gene network perturbation and hiPSC engineering |
$704,661 |
University of California, San Diego |
Ziwei Huang |
Quest – Discovery Stage Research Projects |
Development of a new therapeutic for directing target specific stem cell migration and treatment |
$1,129,512 |